wilate® vWF/FVIII Complex

Wilate® is a von Willebrand Factor / Coagulation Factor VIII Complex (Human) indicated for:

- The treatment of spontaneous and trauma-induced bleeding episodes in patients with severe von Willebrand disease (VWD) as well as patients with mild or moderate VWD in whom the use of desmopressin is known or suspected to be ineffective or contraindicated.
- Clinical trials to evaluate the safety and efficacy of prophylactic dosing with Wilate® to prevent spontaneous bleeding have not been conducted in vWD subjects.
- Wilate® is not indicated for the prophylaxis of spontaneous bleeding episodes, or the prevention of excessive bleeding during and after surgery in VWD patients.
- Wilate® is also not indicated for Hemophilia A

For indications, dosing and other information, please refer to the prescribing information.

wilate® vWF/FVIII Complex ‐ Octapharma

Size:
500 iu, 5 mL vial
NDC #:
67467-0182-01
Download:
PI
Size:
1000 iu, 5 mL vial
NDC #:
67467-0182-02
Download:
PI